You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives
|
|---|---|
| Published in |
Frontiers in oncology, April 2024
|
| DOI | 10.3389/fonc.2024.1394048 |
| Pubmed ID | |
| Authors |
Ricardo D. Parrondo, Sikander Ailawadhi, Claudio Cerchione |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 2 | 67% |
| Members of the public | 1 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2024.
All research outputs
#15,370,760
of 25,838,141 outputs
Outputs from Frontiers in oncology
#4,531
of 22,812 outputs
Outputs of similar age
#90,930
of 236,319 outputs
Outputs of similar age from Frontiers in oncology
#36
of 397 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,812 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,319 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 397 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.